Risk assessment in pulmonary arterial hypertension

doi:10.1183/13993003.02606-2017

Comment

. 2018 Mar 29;51(3):1702606.

doi: 10.1183/13993003.02606-2017. Print 2018 Mar.

Risk assessment in pulmonary arterial hypertension

Marius M Hoeper^{1

2}, David Pittrow³, Christian Opitz⁴, J Simon R Gibbs⁵, Stephan Rosenkranz^{6

7}, Ekkehard Grünig^{2

8}, Karen M Olsson^{9

2}, Doerte Huscher¹⁰

Affiliations

¹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany hoeper.marius@mh-hannover.de.
² German Center of Lung Research (DZL), Germany.
³ Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany.
⁴ Dept of Cardiology, DRK Kliniken Berlin Westend, Berlin, Germany.
⁵ Dept of Cardiology, National Heart and Lung Institute, Imperial College London, London, UK.
⁶ Clinic III for Internal Medicine (Cardiology) and Center for Molecular Medicine (CMMC), University of Cologne, Cologne, Germany.
⁷ The Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.
⁸ Thoraxclinic at the University Hospital Heidelberg, Heidelberg, Germany.
⁹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
¹⁰ Epidemiology Unit, German Rheumatism Research Centre, A. Leibniz Institute, Berlin, Germany.

PMID: 29599117
DOI: 10.1183/13993003.02606-2017

Free article

Comment

Risk assessment in pulmonary arterial hypertension

Marius M Hoeper et al. Eur Respir J. 2018.

Free article

. 2018 Mar 29;51(3):1702606.

doi: 10.1183/13993003.02606-2017. Print 2018 Mar.

Authors

Marius M Hoeper^{1

2}, David Pittrow³, Christian Opitz⁴, J Simon R Gibbs⁵, Stephan Rosenkranz^{6

7}, Ekkehard Grünig^{2

8}, Karen M Olsson^{9

2}, Doerte Huscher¹⁰

Affiliations

¹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany hoeper.marius@mh-hannover.de.
² German Center of Lung Research (DZL), Germany.
³ Institute for Clinical Pharmacology, Medical Faculty, Technical University, Dresden, Germany.
⁴ Dept of Cardiology, DRK Kliniken Berlin Westend, Berlin, Germany.
⁵ Dept of Cardiology, National Heart and Lung Institute, Imperial College London, London, UK.
⁶ Clinic III for Internal Medicine (Cardiology) and Center for Molecular Medicine (CMMC), University of Cologne, Cologne, Germany.
⁷ The Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.
⁸ Thoraxclinic at the University Hospital Heidelberg, Heidelberg, Germany.
⁹ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
¹⁰ Epidemiology Unit, German Rheumatism Research Centre, A. Leibniz Institute, Berlin, Germany.

PMID: 29599117
DOI: 10.1183/13993003.02606-2017

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: M.M. Hoeper reports receiving personal fees from Actelion, Bayer, GSK, Pfizer, Gilead and Merck, during the conduct of the study. Conflict of interest: D. Pittrow reports receiving personal fees from Actelion, Aspen, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Novartis, Pfizer and AstraZeneca, outside the submitted work. Conflict of interest: C. Opitz reports receving personal fees from Actelion, Bayer, GSK, Pfizer and Novartis, during the conduct of the study. Conflict of interest: J.S.R. Gibbs reports receiving personal fees from Actelion, Bayer, GSK, Pfizer, MSD, Bellerophon and Arena, during the conduct of the study. Conflict of interest: S. Rosenkranz reports receving grants and personal fees from Actelion, Bayer, Pfizer, Novartis and United Therapeutics, and personal fees from GSK, Gilead and MSD, during the conduct of the study. Conflict of interest: E. Grünig reports receiving personal fees from Actelion, Bayer, GSK, Pfizer, United Therapeutics and MSD, outside the submitted work. Conflict of interest: K.M. Olsson reports receiving personal fees from Actelion, Bayer, GSK, Pfizer and United Therapeutics, during the conduct of the study. Conflict of interest: D. Huscher reports receiving personal fees from Actelion outside the submitted work.

Comment in

Risk assessment in pulmonary arterial hypertension.
Boucly A, Weatherald J, Humbert M, Sitbon O. Boucly A, et al. Eur Respir J. 2018 Mar 29;51(3):1800279. doi: 10.1183/13993003.00279-2018. Print 2018 Mar. Eur Respir J. 2018. PMID: 29599118 No abstract available.

Comment on

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N, Olsson KM, Meyer K, Vizza CD, Vonk-Noordegraaf A, Distler O, Opitz C, Gibbs JSR, Delcroix M, Ghofrani HA, Huscher D, Pittrow D, Rosenkranz S, Grünig E. Hoeper MM, et al. Eur Respir J. 2017 Aug 3;50(2):1700740. doi: 10.1183/13993003.00740-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775047
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, Picard F, de Groote P, Jevnikar M, Bergot E, Chaouat A, Chabanne C, Bourdin A, Parent F, Montani D, Simonneau G, Humbert M, Sitbon O. Boucly A, et al. Eur Respir J. 2017 Aug 3;50(2):1700889. doi: 10.1183/13993003.00889-2017. Print 2017 Aug. Eur Respir J. 2017. PMID: 28775050

Cited by

Ferric carboxymaltose in patients with pulmonary arterial hypertension and iron deficiency: a long-term study.
Kramer T, Wissmüller M, Natsina K, Gerhardt F, Ten Freyhaus H, Dumitrescu D, Viethen T, Hellmich M, Baldus S, Rosenkranz S. Kramer T, et al. J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1501-1512. doi: 10.1002/jcsm.12764. Epub 2021 Sep 9. J Cachexia Sarcopenia Muscle. 2021. PMID: 34498427 Free PMC article.
Echocardiography in Pulmonary Arterial Hypertension: Is It Time to Reconsider Its Prognostic Utility?
Farmakis IT, Demerouti E, Karyofyllis P, Karatasakis G, Stratinaki M, Tsiapras D, Athanassopoulos G, Voudris V, Giannakoulas G. Farmakis IT, et al. J Clin Med. 2021 Jun 26;10(13):2826. doi: 10.3390/jcm10132826. J Clin Med. 2021. PMID: 34206876 Free PMC article. Review.
The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.
Benza RL, Grünig E, Sandner P, Stasch JP, Simonneau G. Benza RL, et al. Eur Respir Rev. 2024 Mar 20;33(171):230183. doi: 10.1183/16000617.0183-2023. Print 2024 Jan 31. Eur Respir Rev. 2024. PMID: 38508664 Free PMC article. Review.
Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review.
Lokhorst C, van der Werf S, Berger RMF, Douwes JM. Lokhorst C, et al. J Am Heart Assoc. 2024 Jul 2;13(13):e034151. doi: 10.1161/JAHA.123.034151. Epub 2024 Jun 21. J Am Heart Assoc. 2024. PMID: 38904230 Free PMC article.
Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing.
Papa S, Scoccia G, Serino G, Adamo FI, Jabbour JP, Caputo A, Boromei M, Filomena D, Laviola D, Maggio E, Manzi G, Mihai A, Recchioni T, Sabusco A, Valeri L, Vinciullo S, Vizza CD, Badagliacca R. Papa S, et al. J Clin Med. 2023 Oct 29;12(21):6840. doi: 10.3390/jcm12216840. J Clin Med. 2023. PMID: 37959305 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Risk assessment in pulmonary arterial hypertension

Affiliations

Risk assessment in pulmonary arterial hypertension

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Conflict of interest statement

Comment in

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical